Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Active Comparator Study of Generex Oral-lyn™ Spray and Injected Human Insulin

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2011 by Generex Biotechnology Corp..
Recruitment status was  Active, not recruiting
Sponsor:
Collaborators:
OSMOS Clinical Research, Inc
PSI Pharma Support Intl
Nextrials, Inc.
eResearch Technology, Inc.
Hoffmann-La Roche
ACM Pivotal Global Central Laboratory
Information provided by:
Generex Biotechnology Corp.
ClinicalTrials.gov Identifier:
NCT00668850
First received: April 24, 2008
Last updated: June 6, 2011
Last verified: June 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: September 2011
  Estimated Primary Completion Date: August 2011 (Final data collection date for primary outcome measure)